Amoroso, Jennifer I.

HRN: 18-44-05  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2022
CEFUROXIME 750MG (VIAL)
07/11/2022
07/18/2022
IV
750mg
Q 8 HRS
UTI
09/20/2022
CEFUROXIME 1.5GM (VIAL)
09/20/2022
09/20/2022
IVTT
1.5gm
LD
Stat CS
Waiting Final Action 
09/20/2022
CEFUROXIME 1.5GM (VIAL)
09/20/2022
09/20/2022
IV
1.5gm
Q8 X 2 More Doses
Post OP Prophylaxis
Waiting Final Action 
09/20/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/20/2022
09/27/2022
IV
500mg
Q8
Post OP Prophylaxis
Waiting Final Action 
09/22/2022
CEFUROXIME 500MG (TAB)
09/22/2022
09/29/2022
ORAL
500mg
BID
Post CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: